JEWEL ROTELLA: Open Payments
NPI 1558790303 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 15 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $289 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $145 |
| ABBVIE INC. | 4 | $125 |
| BLUEWIND MEDICAL | 3 | $83 |
| Octapharma USA, Inc. | 1 | $40 |
| Biogen, Inc. | 1 | $28 |
Products named: GEMTESA, BOTOX, REVI, FIBRYGA, ZURZUVAE.
Industry payments across TX — which companies pay providers there.
